代谢综合症：临床设置的病第一时间准备.pptVIP

Age-Adjusted Prevalence of the MetS: Results from the NHANES III Survey* * The Metabolic Syndrome: Ready for Prime Time in Clinical Settings? Yuling Hong, MD, PhD, FAHA* Director, Biostatistics and Epidemiology Senior Science and Medicine Advisor American Heart Association The presentation does not necessarily represent the official position of the American Heart Association Outline Evolution of the the Metabolic Syndrome( MetS). Clinical definitions and the implications. Major health consequences of the MetS. Is the metabolic syndrome a useful marker of CHD above and beyond the risk as